The Surge of Sensationalist COVID-19 AI Research AI research using hastily gathered data for COVID-19 is a dangerous trend does not help patients or physicians and damages the AI community's reputation.
Treatment and Prognosis of Mediastinitis Mediastinal infections are primarily related to surgery, perforation of the esophagus and infectious spread from adjacent regions.
What is Organogenesis? The process of organogenesis is the formation of organs during embryonic development. This article looks at the various organs formed.
Could beta-blockers be a potential treatment for COVID-19? Dr. Nirmal Robinson, Dr. Vincenzo Desiderio and Dr. Antonio Barbieri News-Medical spoke to researchers about their latest research into beta-blockers, and how they could potentially be used to treat COVID-19.
The American Lung Association say to wear masks to stop the spread of COVID-19; Here’s why Dr. Albert Rizzo Dr. Albert Rizzo speaks to News-Medical about the importance of wearing masks to help control the spread of COVID-19.
The Prospects of Semaglutide for Treatment of Type 2 Diabetes Patients Dr. Jan Westerink In this interview, News-Medical talks to Dr. Jan Westerink about recent studies into Novo Nordisk’s semaglutide and its potential benefits for Type 2 Diabetes patients, that he and Novo Nordisk collaborated on.
Could beta-blockers be a potential treatment for COVID-19? Dr. Nirmal Robinson, Dr. Vincenzo Desiderio and Dr. Antonio Barbieri News-Medical spoke to researchers about their latest research into beta-blockers, and how they could potentially be used to treat COVID-19.
The American Lung Association say to wear masks to stop the spread of COVID-19; Here’s why Dr. Albert Rizzo Dr. Albert Rizzo speaks to News-Medical about the importance of wearing masks to help control the spread of COVID-19.
The Prospects of Semaglutide for Treatment of Type 2 Diabetes Patients Dr. Jan Westerink In this interview, News-Medical talks to Dr. Jan Westerink about recent studies into Novo Nordisk’s semaglutide and its potential benefits for Type 2 Diabetes patients, that he and Novo Nordisk collaborated on.